VirusesMicrobiologyPeer-reviewed journal article
Human Herpes Virus 8 Oral Shedding Heterogeneity is Due to Varying Rates of Reactivation from Latency and Immune Containment
David A. SwaniD, Elizabeth M. KrantziD, Catherine Byrne, Fred Machyo Okuku, Janet Nankoma, Innocent MutyabaiD, Warren T. PhippsiD, Joshua Tisdell SchifferiD
- Citations
- 1
- FWCI
- 0.38
- Field percentile
- top 35%
Abstract
Human herpesvirus-8 (HHV-8) is a gamma herpesvirus linked to the development of Kaposi sarcoma (KS). KS is more common in persons living with HIV (PLWH), but endemic KS in HIV-negative individuals is also common in sub-Saharan Africa. HHV-8 shedding occurs in the oral mucosa and is likely responsible for transmission. The mechanistic drivers of different HHV-8 shedding patterns in infected individuals are unknown. We applied stochastic mathematical models to a longitudinal study of HHV-8 oral shedding in 295 individuals in Uganda who were monitored daily with oral swabs. Participants were divided into four groups based on whether they were HIV-negative or positive as well as KS-negative or positive. In all groups, we observed a wide variance of shedding patterns, including no shedding, episodic low viral load shedding, and persistent high viral load shedding. Our model closely replicates patterns in individual data and attributes higher shedding rates to increased rates of viral reactivation, and lower median viral load values to more rapid and effective engagement of cytolytic immune responses. Our model provides a framework for understanding different shedding patterns observed in individuals with HHV-8 infection. KeypointsHHV8 shedding rate is mosty determined by rate of reactivation from latency while viral loads is mostly dteremined by peripheral immune responses. DAS performed all mathematical modeling and editied the paper; EMK performed statistical analysis and edited the paper; CB assisted with modeling; FO, JN and IM designed and implemented the clinical protocols; WP designed and implemented the clinical protocols and edited the paper; JTS conceived the study and write the paper.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Kaposi sarcoma-associated herpesvirus infection in HIV patients: potential role of HIV-associated extracellular vesicles
- HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma-like Tumors into Immunocompetent Mice
Julián Naipauer, Ezequiel Lacunza, … Umakant Sharma·Journal of Medical VirologyPeer-reviewed·Jun 29, 2026
- Kaposi Sarcoma herpesvirus reactivation and replication are dispensable for cell-lineage specific tumorigenesis in whole genome transgenic mice
Kyle Shifflett, Anthony B. Eason, … Dirk P. Dittmer·bioRxiv·Jun 14, 2026
- In depth characterisation of the tumour microenvironment reveals HHV-8 dependent immune regulation in HIV-associated and classic Kaposi Sarcoma.
Claudia Angela Maria Fulgenzi, Alessia Dalla Pria, … David James Pinato·British Journal of CancerPeer-reviewed·Aug 5, 2026
- Increased oral Epstein-Barr virus shedding with HIV-1 co-infection is due to a combination of B cell activation and impaired cellular immune control
C. M. Byrne, C. Johnson, … S. Gantt·bioRxiv·Mar 24, 2019
- Tumor-specific changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma
C. Santiago, J. D. Goldman, … J. I. Mullins·PLOS PathogensPeer-reviewed·Jan 19, 2021